Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-108050
Filing Date
2024-10-11
Accepted
2024-10-11 16:15:28
Documents
1
Group Members
SAMSARA BIOCAPITAL GP, LLCSRINIVAS AKKARAJU

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2426046d1_sc13g.htm SC 13G 91585
  Complete submission text file 0001104659-24-108050.txt   93306
Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Subject) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92480 | Film No.: 241367726
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301
Business Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301 (650) 285-4270
Samsara BioCapital, L.P. (Filed by) CIK: 0001699737 (see all company filings)

EIN.: 813958301 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G